German PMS trial (AWB) to evaluate therapy in reflux disease and NSAR-symptoms

Study identifier:1312004007

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

German PMS trial (AWB) to evaluate therapy in reflux disease and NSAR-symptoms

Medical condition

Gastroesophageal Reflux

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

67130

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Sept 2005

Primary Completion Date: -

Study Completion Date: 01 Dec 2005

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions
1 patients with GERD or NSAID-related ulcers	-

"There is no result for the study"

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=1506&filename=CSR-1312004007.pdf
Download
CSR-1312004007.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Germany Clinical Study

+ 0049 4103 708 3707

service.center@astrazeneca.com

Investigators

Principal Investigator

Kai Richter

AstraZeneca Medical Department

German PMS trial (AWB) to evaluate therapy in reflux disease and NSAR-symptoms

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=1506&filename=CSR-1312004007.pdf

CSR-1312004007.pdf

Trial Results Summaries

Contacts

Contact

Investigators

Principal Investigator